HVIIR
Hennessy Capital Investment Corp. VII
No data for this timeframe.
Vol
SEC Reports6
Recent Activity
Jun 2, 2026
SEC
Hennessy Capital Investment Corp. VII (HVII) entered into a second omnibus amendment to its business combination agreeme
8-K — Impact 4/10
May 6, 2026
SEC
ONE Nuclear Energy published a LinkedIn post on May 5, 2026, promoting its pending business combination with Hennessy Ca
425 — Impact 3/10
May 5, 2026
SEC
Hennessy Capital Investment Corp. VII announced that Benchmark Company initiated coverage on HVII with a 'Buy' rating an
425 — Impact 6/10
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 3 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 5.3/10.
NEUTRAL
8-K
4/10
Hennessy Capital Investment Corp. VII (HVII) entered into a second omnibus amendment to its business
Jun 2, 2026
NEUTRAL
425
3/10
ONE Nuclear Energy published a LinkedIn post on May 5, 2026, promoting its pending business combinat
May 6, 2026
BULLISH
425
6/10
Hennessy Capital Investment Corp. VII announced that Benchmark Company initiated coverage on HVII wi
May 5, 2026
BULLISH
425
7/10
Hennessy Capital Investment Corp. VII and ONE Nuclear Energy LLC filed an M&A communication featurin
Apr 10, 2026
BULLISH
425
7/10
Hennessy Capital Investment Corp. VII and ONE Nuclear Energy LLC filed an M&A communication to promo
Apr 9, 2026
NEUTRAL
425
5/10
Hennessy Capital Investment Corp. VII and ONE Nuclear Energy LLC filed an amended registration state
Apr 7, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | 0.0% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.